BioSpace News Archive

Business

Devonian Signs a Binding Letter of Intent with Histapharm Inc. to Extract and Manufacture Their Proprietary Botanical Pharmaceutical Product and to Enter into a Strategic Partnership for the Development of New Products

The LOI also includes the set-up of a Strategic Partnership focused on the development of new products for dermatological applications.

June 3, 2019
·
6 min read
Drug Development

Viracta Presents New Clinical Results on Lead Epigenetic Drug Candidate for EBV-Associated Lymphomas at the 2019 ASCO Annual Meeting

Viracta Therapeutics, Inc. presented updated results today at the 2019 ASCO Annual Meeting from the Ph1b portion of the ongoing Phase 1b/2 clinical trial of nanatinostat in combination with the antiviral valganciclovir for the treatment of relapsed/refractory EBV-associated lymphomas.

June 3, 2019
·
4 min read
BioCapital

New Shimadzu MALDImini-1 Digital Ion Trap Mass Spectrometer Provides Fast, High-Sensitivity Measurements through an Ultra-Compact Design

Shimadzu Scientific Instruments (SSI) announces the release of the MALDImini™-1, the first commercially available compact MALDI digital ion trap mass spectrometer.

June 3, 2019
·
2 min read
BioMidwest

Massachusetts Life Sciences Center launches new Seed Fund to catalyze life sciences innovations in underserved regions

Today, the Massachusetts Life Sciences Center (MLSC) announced the launch of its new Seed Fund to catalyze life sciences development and innovations in under-served regions.

June 3, 2019
·
7 min read
Deals

LabCorp Announces New Term Loan Facility

On June 3, 2019, LabCorp® entered into a new Term Loan Credit Agreement, which provides for a two-year term loan credit facility in the principal amount of $850 million.

June 3, 2019
·
3 min read
Pharm Country

BioXcel Therapeutics Announces FDA Clearance of IND Application for Triple Combination in Pancreatic Cancer and CTA Acceptance for Double Combination in Aggressive Form of Prostate Cancer (tNEPC) for Lead Immuno-Oncology Program, BXCL701

BioXcel Therapeutics, Inc. (BTI) (Nasdaq: BTAI), today announced an update of its immuno-oncology program for BXCL701, an orally-available systemic innate-immune activator with dual mechanisms of action.

June 3, 2019
·
9 min read
Policy

Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa - June 3, 2019

Aadi Bioscience, Inc. released preliminary data on the ongoing nab-sirolimus registration trial for Advanced Malignant PEComa - a rare form of sarcoma for which there is no currently approved therapy.

June 3, 2019
·
8 min read
BioMidwest

Ascentage Pharma presents new clinical data of apoptosis-targeted drug candidates APG-115 and APG-1387 at 2019 ASCO

Ascentage Pharma announced that the company presented new data of two apoptosis-targeted drug candidates APG-115 and APG-1387 at the 55th Annual Meeting of the American Society of Clinical Oncology.

June 3, 2019
·
6 min read
Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC)

Innovent Biologics, Inc. announced that the preliminary results of efficacy and safety of sintilimab, the anti-PD-1 antibody that co-developed with Eli Lilly and Company, in combination with CAPOX in first-line gastric or gastroesophageal junction carcinoma were presented by poster at the 55th annual meeting of the American Society of Clinical Oncology

June 3, 2019
·
6 min read
Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical Hodgkin’s Lymphoma

Innovent Biologics, Inc. announced that the results of extended follow-up on sintilimab, the anti-PD-1 antibody that co-developed with Eli Lilly and Company, for relapsed/refractory classical Hodgkin’s lymphoma were presented by poster at the 55th annual meeting of the American Society of Clinical Oncology

June 3, 2019
·
6 min read